Nociceptin/orphanin FQ and drugs of abuse

被引:85
作者
Ciccocioppo, R [1 ]
Angeletti, S
Panocka, I
Massi, M
机构
[1] Univ Camerino, Dept Pharmacol Sci & Expt Med, I-62032 Camerino, Italy
[2] Mil Hyg & Epidemiol, Dept Pharmacol & Toxicol, PL-01163 Warsaw, Poland
关键词
nociceptin; orphanin FQ; ORL1; receptors; opioids; brain reward system; drug abuse; reward; reinforcement;
D O I
10.1016/S0196-9781(00)00245-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nociceptin/orphanin FQ (NC) binds with high affinity to the opioid receptor-like 1 (ORL1) receptor. NC has been reported to block opioid-induced supraspinal analgesia, and it has been proposed that it may represent a functional antiopioid peptide in the control of brain nociceptive processes. The wide distribution of NC and of its receptors in the central nervous system suggests, however, that it may be involved in the control of a variety of biologic functions. Increasing evidence indicates that it may influence the rewarding and reinforcing properties of drugs of abuse. NC has been shown to abolish the rewarding properties of ethanol and morphine in the place conditioning paradigm, to reduce ethanol consumption in alcohol-preferring rats and to inhibit stress-induced alcohol-seeking behavior. These findings suggest that drugs directed at central NC receptors may represent an interesting approach to the treatment of ethanol and opiate abuse. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1071 / 1080
页数:10
相关论文
共 117 条
[81]  
Parsons LH, 1998, J NEUROSCI, V18, P10078
[82]   DOPAMINE IN THE NUCLEUS ACCUMBENS DURING COCAINE SELF-ADMINISTRATION AS STUDIED BY INVIVO MICRODIALYSIS [J].
PETTIT, HO ;
JUSTICE, JB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (04) :899-904
[83]  
PIERETTI S, 1999, REGUL PEPTIDES, V80, P126
[84]  
Pohorecky L. A., 1998, Alcoholism Clinical and Experimental Research, V22, p159A
[85]   Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist [J].
Polidori, C ;
Calo', G ;
Ciccocioppo, R ;
Guerrini, R ;
Regoli, D ;
Massi, M .
PSYCHOPHARMACOLOGY, 2000, 148 (04) :430-437
[86]  
POLIDORI C, 2000, PEPTIDES, V21
[87]   Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study [J].
Rabinowitz, J ;
Cohen, H ;
Tarrasch, R ;
Kotler, M .
DRUG AND ALCOHOL DEPENDENCE, 1997, 47 (02) :77-86
[88]   ORPHANIN-FQ - A NEUROPEPTIDE THAT ACTIVATES AN OPIOID-LIKE G-PROTEIN-COUPLED RECEPTOR [J].
REINSCHEID, RK ;
NOTHACKER, HP ;
BOURSON, A ;
ARDATI, A ;
HENNINGSEN, RA ;
BUNZOW, JR ;
GRANDY, DK ;
LANGEN, H ;
MONSMA, FJ ;
CIVELLI, O .
SCIENCE, 1995, 270 (5237) :792-794
[89]   Structure-activity relationship studies on the novel neuropeptide orphanin FQ [J].
Reinscheid, RK ;
Ardati, A ;
Monsma, FJ ;
Civelli, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14163-14168
[90]   Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities [J].
Reinscheid, RK ;
Higelin, J ;
Henningsen, RA ;
Monsma, FJ ;
Civelli, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) :1490-1495